Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1970 Jul;118(3):513–518. doi: 10.1042/bj1180513

Effects of 3-methylcholanthrene pretreatment on microsomal hydroxylation of 2-acetamidofluorene by various rat hepatomas

Prabhakar D Lotlikar 1
PMCID: PMC1179220  PMID: 4319545

Abstract

1. The effects of 3-methylcholanthrene pretreatment on both N- and ring hydroxylation of 2-acetamidofluorene by microsomal preparations from various well-differentiated and poorly differentiated hepatomas, primary tumours and their host livers and kidneys were studied. 2. Well-differentiated Morris hepatomas 5123C, 5123D, 5123CTC and 7800 and their host livers had low hydroxylating activity. Pretreatment with 3-methylcholanthrene caused a several-fold increase in both N- and ring hydroxylation in the host livers whereas in all tumours except 5123CTC it caused a many-fold increase only in ring hydroxylation. 5123CTC tumour in addition showed a fourfold increase in N-hydroxylating activity. 3. Hydroxylating activities of poorly differentiated Morris hepatoma 7288CTC and Novikoff hepatoma were low and they could not be altered by 3-methylcholanthrene pretreatment. 4. Primary hepatomas produced by administration of 4-dimethylamino-3′-methylazobenzene could be stimulated to some extent on 3-methylcholanthrene pretreatment; however, primary mammary tumour produced by administration of 3-methylcholanthrene was not responsive to 3-methycholanthrene pretreatment. 5. Like host livers, kidneys of tumour-bearing animals could also be stimulated to some extent by 3-methylcholanthrene pretreatment.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOOTH J., BOYLAND E. The biochemistry of aromatic amines. III. Enzymic hydroxylation by rat-liver microsomes. Biochem J. 1957 May;66(1):73–78. doi: 10.1042/bj0660073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CONNEY A. H., BROWN R. R., MILLER J. A., MILLER E. C. The metabolism of methylated aminoazo dyes. VI. Intracellular distribution and properties of the demethylase system. Cancer Res. 1957 Jul;17(6):628–633. [PubMed] [Google Scholar]
  3. CONNEY A. H., BURNS J. J. INDUCED SYNTHESIS OF OXIDATIVE ENZYMES IN LIVER MICROSOMES BY POLYCYCLIC HYDROCARBONS AND DRUGS. Adv Enzyme Regul. 1963;1:189–214. doi: 10.1016/0065-2571(63)90018-9. [DOI] [PubMed] [Google Scholar]
  4. CONNEY A. H., DAVISON C., GASTEL R., BURNS J. J. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther. 1960 Sep;130:1–8. [PubMed] [Google Scholar]
  5. CONNEY A. H., MILLER E. C., MILLER J. A. Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J Biol Chem. 1957 Oct;228(2):753–766. [PubMed] [Google Scholar]
  6. CRAMER J. W., MILLER J. A., MILLER E. C. N-Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. J Biol Chem. 1960 Mar;235:885–888. [PubMed] [Google Scholar]
  7. CRAMER J. W., MILLER J. A., MILLER E. C. The hydroxylation of the carcinogen 2-acetylaminofluorene by rat liver: stimulation by pretreatment in vivo with 3-methylcholanthrene. J Biol Chem. 1960 Jan;235:250–256. [PubMed] [Google Scholar]
  8. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  9. Enomoto M., Miyake M., Sato K. Carcinogenicity in the hamster of simultaneously administered 2-acetamidofluorene and 3-methylcholanthrene. Gan. 1968 Jun;59(3):177–186. [PubMed] [Google Scholar]
  10. GELBOIN H. V., BLACKBURN N. R. THE STIMULATORY EFFECT OF 3-METHYLCHOLANTHRENE ON BENZPYRENE HYDROXYLASE ACTIVITY IN SEVERAL RAT TISSUES: INHIBITION BY ACTINOMYCIN D AND PUROMYCIN. Cancer Res. 1964 Feb;24:356–360. [PubMed] [Google Scholar]
  11. GELBOIN H. V., BLACKBURN N. R. THE STIMULATORY EFFECT OF 3-METHYLCHOLANTHRENE ON MICROSOMAL AMINO ACID INCORPORATION AND BENZPYRENE HYDROXYLASE ACTIVITY AND ITS INHIBITION BY ACTINOMYCIN D. Biochim Biophys Acta. 1963 Aug 20;72:657–660. [PubMed] [Google Scholar]
  12. HART L. G., ADAMSON R. H., MORRIS H. P., FOUTS J. R. THE STIMULATION OF DRUG METABOLISM IN VARIOUS RAT HEPATOMAS. J Pharmacol Exp Ther. 1965 Jul;149:7–15. [PubMed] [Google Scholar]
  13. Hlavica P., Kiese M. N-oxygenation of N-alkyl- and N,N-dialkylanilines by rabbit liver microsomes. Biochem Pharmacol. 1969 Jun;18(6):1501–1509. doi: 10.1016/0006-2952(69)90265-2. [DOI] [PubMed] [Google Scholar]
  14. IRVING C. C. ENZYMATIC N-HYDROXYLATION OF THE CARCINOGEN 2-ACETYLAMINOFLUORENE AND THE METABOLISM OF N-HYDROXY-2-ACETYLAMINOFLUORENE-9-14C IN VITRO. J Biol Chem. 1964 May;239:1589–1596. [PubMed] [Google Scholar]
  15. KAMPFFMEYER H., KIESE M. THE EFFECT OF CARBON MONOXIDE ON THE HYDROXYLATION OF ANILINE AND N-ETHYLANILINE BY MICROSOMAL ENZYMES. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Feb 2;250:1–8. doi: 10.1007/BF00246877. [DOI] [PubMed] [Google Scholar]
  16. Lotlikar P. D., Enomoto M., Miller J. A., Miller E. C. Species variations in the N- and ring-hydroxylation of 2-acetylaminofluorene and effects of 3-methylcholanthrene pretreatment. Proc Soc Exp Biol Med. 1967 Jun;125(2):341–346. doi: 10.3181/00379727-125-32086. [DOI] [PubMed] [Google Scholar]
  17. Lotlikar P. D., Miller E. C., Miller J. A., Margreth A. The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations. Cancer Res. 1965 Nov;25(10):1743–1752. [PubMed] [Google Scholar]
  18. MILLER E. C., MILLER J. A., BROWN R. R., MACDONALD J. C. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res. 1958 May;18(4):469–477. [PubMed] [Google Scholar]
  19. MILLER J. A., CRAMER J. W., MILLER E. C. The N- and ringhydroxylation of 2-acetylaminofluorene during carcinogenesis in the rat. Cancer Res. 1960 Jul;20:950–962. [PubMed] [Google Scholar]
  20. MIYAJI T., MOSZKOWSKI L. I., SENOO T., OGATA M., ODA T., KAWAI K., SAYAMA Y., ISHIDA H., MATSUO H. [Inhibition of 2-acetylaminofluorene tumors in rats with simultaneously fed 20-methylcholanthrene, 9:10-dimethyl-1:2-benzanthracene and chrysene, and consideration of sex difference in tumor genesis with 2-acetyl-aminoflurene]. Gan. 1953 Sep;44(2-3):281–283. [PubMed] [Google Scholar]
  21. MORRIS H. P., SOBER H. A., WEISBURGER E. K., WEISBURGER J. H. Chromatographic separation of some metabolites of the carcinogen N-2-fluorenylacetamide. J Natl Cancer Inst. 1956 Sep;17(3):363–374. [PubMed] [Google Scholar]
  22. Morris H. P. Studies on the development, biochemistry, and biology of experimental hepatomas. Adv Cancer Res. 1965;9:227–302. doi: 10.1016/s0065-230x(08)60448-0. [DOI] [PubMed] [Google Scholar]
  23. NEUBERT D., HOFFMEISTER I. [The activity of various TPN-dependent. liver-specific enzyme systems in the "microsome" fraction of an experimental rat hepatoma]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;239:234–244. [PubMed] [Google Scholar]
  24. POIRIER L. A., MILLER J. A., MILLER E. C. The N- and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog. Cancer Res. 1963 Jun;23:790–800. [PubMed] [Google Scholar]
  25. Rogers L. A., Morris H. P., Fouts J. R. The effect of phenobarbital on drug metabolic enzyme activity, ultrastructure and growth of a "minimal deviation" hepatoma (Morris 7800). J Pharmacol Exp Ther. 1967 Jul;157(1):227–244. [PubMed] [Google Scholar]
  26. SEAL U. S., GUTMANN H. R. The metabolism of the carcinogen N-(2-fluorenyl) acetamide by liver cell fractions. J Biol Chem. 1959 Mar;234(3):648–654. [PubMed] [Google Scholar]
  27. SHATTON J. B., DONNELLY A. J., WEINHOUSE S. Metabolism of neoplastic tissues. XVI. Glucokinase activity and glycogen levels during hepatocarcinogenesis by azo dyes. Cancer Res. 1962 Dec;22:1372–1380. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES